日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low status

HercepTest™ mAb pharmDx (Dako Omnis, GE001) 与 Ventana PATHWAY anti-HER-2/neu (4B5) 在乳腺癌中的比较:与 HER2 扩增和 HER2 低状态的相关性

Josef Rüschoff #, Michael Friedrich #, Iris Nagelmeier, Matthias Kirchner, Lena M Andresen, Karin Salomon, Bryce Portier, Simone T Sredni, Hans Ulrich Schildhaus, Bharat Jasani, Marius Grzelinski, Giuseppe Viale

FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis

FGFR3 mRNA 过表达定义了一部分预后较差的寡转移性结直肠癌。

Fromme, Julia Elisabeth; Schmitz, Katja; Wachter, Astrid; Grzelinski, Marius; Zielinski, Dirk; Koppel, Christina; Conradi, Lena-Christin; Homayounfar, Kia; Hugo, Tabea; Hugo, Sara; Lukat, Laura; Rüschoff, Josef; Ströbel, Philipp; Ghadimi, Michael; Beißbarth, Tim; Reuter-Jessen, Kirsten; Bleckmann, Annalen; Schildhaus, Hans-Ulrich